MIR4472-2

Across TCGA pan-cancer cohorts, MIR4472-2 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR4472-2 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher MIR4472-2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4472-2 expression acts as an unfavorable survival marker, although some lineages such as STAD show a favorable association.

LUSC, DLBC, and COAD are the cancer types where MIR4472-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	III,IV	0.402	0.705	.006	75	view →
DLBC	OS	Tertile	II,III,IV	0.172	0.949	<.001	54	view →
COAD	OS	Tertile	All	0.144	0.799	.001	45	view →
STAD	OS	Tertile	IV	1.000	0.294	.019	38	view →
READ	DFS	Tertile	III,IV	0.059	0.761	<.001	36	view →
THCA	DFS	Tertile	IV	0.270	0.832	.014	21	view →
PAAD	OS	Tertile	II,III,IV	0.253	0.560	.013	18	view →
THYM	DFS	Tertile	II,III,IV	0.405	0.861	.005	9	view →
SARC	OS	Tertile	All	0.241	0.766	.022	9	view →
UCEC	OS	Tertile	All	0.796	0.881	.042	6	view →
LUAD	OS	Tertile	All	0.710	0.840	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MIR4472-2–LUSC (OS)

Open the LUSC breakdown →